Chris Garabedian, President and CEO Sarepta Therapeutics, Inc. (NASDAQ:SRPT), announced that the Phase IIb clinical study on its first product, eteplirsen, will have its results submitted to the FDA by the end of the year, with a launch slated for mid next-year if approved. He was speaking at the Canaccord Genuity 34th Annual Growth Conference at the Intercontinental Hotel in Boston, Massachusetts. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) belongs to Healthcare sector. Its weekly performance is 4.68%. On last trading day company shares ended up $22.36. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) distance from 50-day simple moving average (SMA50) is -13.00%.
Google Inc (NASDAQ:GOOGL) is launching an ad-free subscription-based YouTube service, according to leaked screenshots, the latest step in the evolution of media consumption from the traditional tube to online and mobile. Google Inc (NASDAQ:GOOGL) shares moved up 0.74% in last trading session and ended the day at $597.11. GOOGL Gross Margin is 58.90% and its return on assets is 11.60%. Google Inc (NASDAQ:GOOGL) quarterly performance is 10.50%.
B&G Foods Inc. (NYSE:BGS) is pleased to announce a tasty transformation of the original melba toast brand, Old London®. The relaunch of Old London Melba features sophisticated and colorful new packaging, contemporary flavors and an easy approach to everyday eating and entertaining. Old London Melba is also unveiling a partnership with Lisa Lillien (a.k.a. Hungry Girl), a go-to resource for guilt-free eating, as well as new product offering, Old London Melba Toasts Ancient Grains. On 19 August, B&G Foods Inc. (NYSE:BGS) shares moved up 0.52% and was closed at $29.19. BGS EPS growth in last 5 year was 29.40%. B&G Foods Inc. (NYSE:BGS) year to date (YTD) performance is -12.05%.
Repros Therapeutics (NASDAQ:RPRX) CFO Katherine Anderson bought 2,000 shares of Repros Therapeutics stock on the open market in a transaction dated Thursday, August 14th. The stock was purchased at an average price of $13.85 per share, with a total value of $27,700.00. Repros Therapeutics Inc. (NASDAQ:RPRX) ended the last trading day at $14.83. Company weekly volatility is calculated as 4.10%and price to cash ratio as 5.04. Repros Therapeutics Inc. (NASDAQ:RPRX) showed a weekly performance of 6.08%.
Tejon Ranch (NYSE:TRC) VP Joseph E. Drew unloaded 2,000 shares of Tejon Ranch stock on the open market in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $28.12, for a total value of $56,240.00. Following the completion of the transaction, the vice president now directly owns 72,206 shares of the company’s stock, valued at approximately $2,030,433. The transaction was disclosed in a legal filing with the Securities & Exchange Commission. Tejon Ranch Co. (NYSE:TRC) shares moved down -0.67% in last trading session and ended the day on $28.36. TRC Gross Margin is 26.50% and its return on assets is 1.40%. Tejon Ranch Co. (NYSE:TRC) quarterly performance is -6.83%.